Pas une boutique. Une base de connaissances clinique.
Chaque protocole documente le mécanisme, les preuves cliniques, la dose, l’escalade, la surveillance et les références — construit peptide par peptide, en commençant par un ensemble pilote.
Retatrutide
Protocole complet — mécanisme, dose, dilution, injection, conservation, surveillance et références.
CJC no-DAC / Ipamorelin
Protocole complet — mécanisme, dose, dilution, injection, conservation, surveillance et références.
BPC-157
Protocole complet — mécanisme, dose, dilution, injection, conservation, surveillance et références.
MOTS-C
Protocole complet — mécanisme, dose, dilution, injection, conservation, surveillance et références.
AOD-9604
Protocole complet — mécanisme, dose, dilution, injection, conservation, surveillance et références.
Retatrutide
Triple GIP/GLP-1/glucagon receptor agonist studied in human clinical trials for metabolic and weight research.
Cagrilintide
Amylin-receptor agonist studied for appetite regulation, often alongside GLP-1 agonists in combination research.
CagriSema
Combination cagrilintide/semaglutide studied for dual amylin and GLP-1 receptor signaling in weight research.
Survodutide
GLP-1/glucagon dual receptor agonist studied for weight management and liver-fat research.
Mazdutide
GLP-1/glucagon dual receptor agonist studied primarily in Chinese clinical trials for weight and metabolic research.
AOD-9604
Modified fragment of human growth hormone (176-191) studied for fat-metabolism research without GH growth effects.
5-Amino-1MQ
Small-molecule NNMT inhibitor studied for fat-metabolism and cellular-energy research.
SNAP-8
Acetyl octapeptide studied topically for expression-line and neuromuscular signaling research in skin.
GHK-Cu
Copper-binding peptide studied in extracellular-matrix and tissue-remodeling pathways.
GLOW
Blended skin-and-repair peptide product (commonly GHK-Cu with repair peptides); exact composition varies by batch.
KLOW
Blended multi-peptide skin-and-repair product (commonly GHK-Cu, BPC-157, TB-500 and Kisspeptin); exact composition varies by batch.
Melanotan I
Melanocortin-1 receptor agonist studied for melanogenesis and photoprotection research.
BPC-157 + TB-500
Combination repair peptide blend studied for tissue-response, vascular-signaling and cell-migration research.
BPC-157
Preclinical investigation of tissue response, vascular signaling and repair pathways.
TB-500
Research associated with thymosin-beta-4-related cell migration and repair signaling.
CJC no-DAC / Ipamorelin
Combination GHRH analog and ghrelin-receptor agonist studied for growth-hormone pulse research.
Tesamorelin
GHRH analog studied for GH-axis research; one formulation is FDA-approved for HIV-associated lipodystrophy.
IGF-1 LR3
Long-arginine3 IGF-1 analog studied for anabolic and growth-factor signaling research.
Ipamorelin
Selective ghrelin-receptor agonist studied for GH release with a comparatively mild side-effect profile.
CJC-1295 With DAC
GHRH analog with drug-affinity complex studied for extended-duration growth-hormone pulse research.
CJC-1295 No DAC
Shorter-acting GHRH analog variant studied for growth-hormone pulse research.
Sermorelin
GHRH(1-29) analog historically studied diagnostically and therapeutically for GH-stimulation research.
GHRP-2
Ghrelin-receptor agonist and growth-hormone secretagogue studied for GH-release research.
GHRP-6
Ghrelin-receptor agonist studied for growth-hormone release and appetite-stimulation research.
Thymosin Alpha-1
Immune-modulating peptide studied in infectious-disease and oncology-adjunct research contexts.
Glutathione
Master antioxidant tripeptide studied for oxidative-stress, detoxification and skin-brightening research.
KPV
C-terminal alpha-MSH fragment studied for anti-inflammatory and gut-healing research without pigmentation effects.
Adamax
Blended nootropic peptide product studied for cognitive and mood-related research; exact composition varies by supplier.
Selank+Semax Blend
Combination of two Russian-origin peptides studied for anxiolytic and nootropic effects.
Semax
ACTH-fragment analog studied in Russian research literature for cognitive and neuroprotective effects.
Melanotan II
Broader melanocortin-receptor agonist studied for pigmentation and libido-related research.
Kisspeptin
GnRH-signaling neuropeptide studied for reproductive hormone regulation, largely in fertility-research contexts.
Oxytocin
Neuropeptide hormone studied for social bonding, trust and some anxiolytic/metabolic research angles.
PT-141
Melanocortin-receptor agonist (bremelanotide) studied for sexual arousal disorders; one formulation is FDA-approved for a specific indication.